Scarica l'app Stockscreener
2.844
2.27%
-0.066
Precedente Chiudi:
$2.91
Aprire:
$2.91
Volume 24 ore:
19,891
Relative Volume:
0.20
Capitalizzazione di mercato:
$7.00M
Reddito:
$77,900
Utile/perdita netta:
$-8.05M
Rapporto P/E:
-0.3081
EPS:
-9.2296
Flusso di cassa netto:
$-7.47M
1 W Prestazione:
-7.96%
1M Prestazione:
-10.14%
6M Prestazione:
-40.50%
1 anno Prestazione:
-61.51%
Intervallo 1D:
$2.81
$2.91
Intervallo di 1 settimana:
$2.81
$3.17
Portata 52W:
$2.3401
$12.03
Aclarion Inc Stock (ACON) Company Profile
Nome
Aclarion Inc
Settore
Industria
Telefono
833 275 2266
Indirizzo
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.844 | 7.00M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
190.12 | 30.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
71.43 | 14.02B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.23 | 10.46B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.40 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
88.80 | 6.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc Borsa (ACON) Ultime notizie
Price to earnings forward of Aclarion, Inc. – BOATS:ACONW - TradingView
Aclarion Announces Texas Spine Care Center as New CLARITY Site - marketscreener.com
Aclarion adds Texas Spine Care Center to CLARITY trial - Investing.com
Aclarion adds Texas Spine Care Center to CLARITY trial By Investing.com - Investing.com Canada
Aclarion expands CLARITY trial with Texas spine center - Stock Titan
Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView
ACON Q1 2026 Earnings: EPS Surpasses Analyst Estimates Despite Lack of Revenue DisclosureFull Year Guidance - dars.gov.et
Enterprise value to EBIT forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
Price to book forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
A412BH Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion, Inc. Actuals & Estimates (NASDAQ:ACON) - TradingView
ACON Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion Inc (ACONW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates with 15% Beat Despite No RevenueGAAP Earnings Report - dars.gov.et
Aclarion Inc (ACONW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc. Warrant (ACONW) Surges 38% From Penny Levels – But Caution WarrantedBPI Bull Correction - Město Břeclav
Aclarion Inc. Holds Steady Near Key Resistance Level (ACON)RTH Profile - dars.gov.et
Aclarion (ACON) upgraded to buy: Here's why - MSN
Aclarion Inc (ACONW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACONW) Institutional Confidence - TradingKey
Aclarion Inc (ACONW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACONW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACONW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACONW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion Inc (ACONW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion board rejects Echo Lake’s $4 per share takeover bid By Investing.com - Investing.com Nigeria
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue AbsenceEarnings Season Outlook - newsline.com
Aclarion Inc. (ACON) Slides Amid Light Trading, Support at $2.96 in FocusTRIN Signal - newsline.com
Aclarion (ACON) Chief Strategy Officer granted 55,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) director receives 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (NASDAQ: ACON) director receives 20,000 RSU equity grant - Stock Titan
Aclarion (ACON) CFO awarded 50,000 restricted stock units set to vest 2027 - Stock Titan
Aclarion (ACON) CEO Brent Ness receives 100,000 RSU equity award - Stock Titan
Aclarion (ACON) director awarded 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) grants 100,000 RSUs to Executive Chairman Thramann - Stock Titan
Aclarion (ACON) director receives 20,000 RSU equity award, total holdings 22,502 shares - Stock Titan
Director granted 20,000 RSUs at Aclarion (NASDAQ: ACON) vesting 2027 - Stock Titan
ACON Q1 2026 Earnings: EPS Beats Estimates Despite No Revenue ReportedMargin Expansion Trends - newsline.com
ACONW Warrants Surge Over 10%: A Closer Look at the Microcap MoveValue Area High - newsline.com
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform - Ortho Spine News
Aclarion Inc. (ACON) Consolidates Near Key Support After Marginal DeclinePrice Target - newsline.com
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub - The Manila Times
Aclarion Inc Azioni (ACON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aclarion Inc Azioni (ACON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
3.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):